Category: Regulatory
Catalyst Oncology Consulting Catalyst Oncology Consulting is focused solely on the development of new treatments in oncology. Catalyst Read Now 
Drug Development Strategy Workshops Catalyst Oncology offers the opportunity to assemble industry-leading experts in a dedicated full- or half-day Read Now 
Profiles of Our Network of Oncology Drug Development Experts Our network offers specialized consulting solutions by listening to your needs and offering flexible solutions. Read Now 
Ensuring Flexibility when Approaching CTIS When Catalyst Oncology implements the European Union Clinical Trial Regulation (EU CTR) across Sponsor studies Read Now 
Navigating the Changing Landscape of Clinical Trials Takeaways from the Clinical Trials in Oncology East Coast I was thrilled to recently chair Read Now 
Policy Changes from Patient Support to Location BIO International 2024 Highlights Biotech companies from all over the globe, including those researching novel, Read Now 
Expanding Clinical Trial Diversity: A Catalyst Values Approach “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community Read Now 
A Reflection on the European Regulatory Framework Historically gaining regulatory approval across multiple countries within the European Union (EU) was segmented, excessively Read Now 
Catalyst is Project Optimus ready, are you? What is Project Optimus? Project Optimus, an initiative from the FDA, seeks to optimize dosing. Read Now